PartnershipUpdated on 25 January 2026
BIOTECH: Finding a strategic partner to develop novel psychitric drugs
About
We would like to find potential strategic partners for funding our Novel Neuropsychiatric Drugs via Computational Multi-Target Drug Design
Similar opportunities
Partnership
Dorit Cohen
Founder & CEO at ReSynapse Therapeutics
Nes Ziona, Israel
Expertise
- Biotech, Pharma and Cosmetics
Elmeri Jokinen
CEO at Aurlide Oy
Turku, Finland
Partnership
Sandra von Meier
Head of Business Development Life Science at Terra Quantum AG
Munich, Germany